Mometasona Alter (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasona Alter, is a potent glucocorticoid corticosteroid presented as a metered‑dose nasal spray for intranasal use. It reduces inflammation associated with allergic rhinitis and nasal polyps, providing symptom relief for adults and children when prescribed by a qualified clinician.

GNH USA supplies Mometasona Alter as a licensed, Good Distribution Practice‑compliant international pharmaceutical supplier, delivering the product to hospitals, pharmacies and clinics worldwide with consistent quality and regulatory adherence for patients across regions.

Mometasone furoate nasal spray is used to treat inflammatory conditions of the nasal passages.

- Allergic rhinitis: Reduces nasal congestion, sneezing, and itching caused by seasonal or perennial allergens. - Nasal polyps: Decreases polyp size and improves nasal airflow, helping to control symptoms. - Nasal congestion due to allergic inflammation: Provides relief of blockage and discharge.

Adverse reactions are generally localized to the nasal cavity, though systemic effects can occur rarely.

Common Side Effects: - Nasal irritation or burning sensation - Epistaxis (nosebleeds) - Headache - Sore throat - Altered taste perception - Cough

Serious or Rare Side Effects: - Nasal septal perforation - Adrenal suppression with prolonged high‑dose use - Cataracts or glaucoma - Severe allergic reaction (anaphylaxis) - Opportunistic infections in immunocompromised patients

Mometasona Alter requires careful use to minimize risks and ensure optimal benefit.

- Pregnancy: Consult a healthcare provider; safety not established. - Breastfeeding: Use only if the benefit outweighs potential risk. - Children: Use as prescribed and monitor for growth effects. - Concurrent systemic corticosteroids: Monitor for additive systemic effects. - Immunocompromised patients: Use with caution due to infection risk. - Store at room temperature: Keep in the original container, protect from moisture and heat.

Mometasona Alter may interact with other medications that affect corticosteroid metabolism or systemic exposure.

Major Interactions (Avoid): - Systemic glucocorticoids: Increased risk of systemic corticosteroid side effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole): May raise local drug exposure.

Moderate Interactions (Monitor Closely): - Moderate CYP3A4 inhibitors (e.g., itraconazole): Monitor for nasal irritation. - Antiretroviral protease inhibitors (e.g., ritonavir): Potentially increased exposure. - Live vaccines: Consider timing of administration.